Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: Adv Drug Deliv Rev. 2023 Jan 25;194:114711. doi: 10.1016/j.addr.2023.114711

Fig.8. Wireless optogenetics enabled by a MLMD.

Fig.8.

(a) Schematic showing MLMD device implanted in the primary motor cortex (M1) and the wireless neuromodulation by MLMD in free-moving mice. (b) The confocal images of C1V1 and C-fos staining in hippocampus regions of the mouse brain in different groups. All scale bars represent 200 μm. (c) The displacement trajectories of mice with different neuromodulation conditions. Reproduced from [88] with permission from Wiley-VCH, Copyright 2021.